Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH

J Thromb Haemost. 2018 Sep;16(9):1891-1894. doi: 10.1111/jth.14219. Epub 2018 Jul 19.

Authors

A A Khorana¹, S Noble², A Y Y Lee³, G Soff⁴, G Meyer⁵, C O'Connell⁶, M Carrier⁷

Affiliations

¹ Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
² Marie Curie Palliative Care Research Centre, Cardiff University, Cardiff, UK.
³ Department of Medicine, University of British Columbia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
⁴ Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Department of Respiratory Disease, Hopital Europeen Georges Pompidou, AP-HP, INSERM CIC1418 and Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
⁶ Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
⁷ Department of Medicine, Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, Ontario, Canada.

PMID: 30027649
DOI: 10.1111/jth.14219

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Anticoagulants / administration & dosage
Anticoagulants / adverse effects
Anticoagulants / therapeutic use*
Antithrombins / administration & dosage
Antithrombins / adverse effects
Antithrombins / therapeutic use
Dabigatran / administration & dosage
Dabigatran / therapeutic use
Dalteparin / therapeutic use
Factor Xa Inhibitors / administration & dosage
Factor Xa Inhibitors / adverse effects
Factor Xa Inhibitors / therapeutic use
Hemorrhage / chemically induced
Humans
Multicenter Studies as Topic
Neoplasms / blood
Neoplasms / complications*
Observational Studies as Topic
Patient Acceptance of Health Care
Prospective Studies
Pulmonary Embolism / drug therapy*
Pulmonary Embolism / etiology
Pulmonary Embolism / prevention & control
Pyrazoles / administration & dosage
Pyrazoles / therapeutic use
Pyridines / administration & dosage
Pyridines / therapeutic use
Pyridones / administration & dosage
Pyridones / therapeutic use
Randomized Controlled Trials as Topic
Recurrence
Rivaroxaban / administration & dosage
Rivaroxaban / therapeutic use
Thiazoles / administration & dosage
Thiazoles / therapeutic use
Venous Thromboembolism / drug therapy*
Venous Thromboembolism / etiology
Venous Thromboembolism / prevention & control
Venous Thrombosis / drug therapy*
Venous Thrombosis / etiology
Venous Thrombosis / prevention & control

Substances

Anticoagulants
Antithrombins
Factor Xa Inhibitors
Pyrazoles
Pyridines
Pyridones
Thiazoles
apixaban
Rivaroxaban
Dabigatran
edoxaban
Dalteparin

Grants and funding

MCCC-FCO-11-C/MCCC_/Marie Curie/United Kingdom